Driss Berdaï

Dr Driss BERDAI, MD, MScDriss Berdaï is involved in Clinical Pharmacology having more than twenty years of academic, regulatory and industrial experience. He is former Head of the Clinical Trials Unit of the French Medicines Agency (ANSM) and Scientific Administrator (scientific advice, orphan drugs, pharmacovigilance) at the European Medicines Agency (EMA, London). He has served Pfizer as Director-Pharmacovigilance and Pharmacoepidemiology. He has been former medical advisor at the French National Health Fund (CNAM-TS).

Presently he is working as a senior consultant in the Departement of Pharmacology, University Hospital of Bordeaux, France. He is also member of the Transparency Committee of the French HTA body, Haute Autorité de Santé (HAS)

www.has-sante.fr

 
 
A voz das pessoas com doenças raras na EuropaEURORDIS A voz internacional das pessoas com doenças raras, Rare Diseases InternacionalRare Disease International Reúne doentes, famílias e especialistas para partilhar experiências num fórum multilinguístico. RareConnect O programa Rare Barometer é uma iniciativa da EURORDIS para a realização de inquéritos para transformar a experiência das pessoas com doenças raras em números e factos que podem ser partilhados com os responsáveis pela tomada de decisões.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Adira ao maior encontro europeu das partes interessadas no âmbito das doenças raras na Conferência Bienal Europeia sobre Doenças Raras e Produtos Órfãos. A ECRD é uma iniciativa da EURORDISEuropean Conference on Rare Diseases